ITMI971011A0 - - Google Patents

Info

Publication number
ITMI971011A0
ITMI971011A0 ITMI971011A ITMI971011A ITMI971011A0 IT MI971011 A0 ITMI971011 A0 IT MI971011A0 IT MI971011 A ITMI971011 A IT MI971011A IT MI971011 A ITMI971011 A IT MI971011A IT MI971011 A0 ITMI971011 A0 IT MI971011A0
Authority
IT
Italy
Application number
ITMI971011A
Other languages
Italian (it)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to IT97MI001011A priority Critical patent/IT1291288B1/it
Publication of ITMI971011A0 publication Critical patent/ITMI971011A0/it
Priority to DE69831829T priority patent/DE69831829D1/de
Priority to AT98107888T priority patent/ATE306493T1/de
Priority to US09/067,711 priority patent/US6169178B1/en
Priority to ES98107888T priority patent/ES2251047T3/es
Priority to EP98107888A priority patent/EP0875516B1/en
Publication of ITMI971011A1 publication Critical patent/ITMI971011A1/it
Application granted granted Critical
Publication of IT1291288B1 publication Critical patent/IT1291288B1/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/0026Oxygen-containing hetero ring cyclic ketals
    • C07J71/0031Oxygen-containing hetero ring cyclic ketals at positions 16, 17
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes
    • C07J71/0015Oxiranes at position 9(11)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT97MI001011A 1997-04-30 1997-04-30 Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22. IT1291288B1 (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IT97MI001011A IT1291288B1 (it) 1997-04-30 1997-04-30 Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.
DE69831829T DE69831829D1 (de) 1997-04-30 1998-04-28 C22-Stereospezifische Herstellung von Pregnan-16,17-Acetal Derivaten
AT98107888T ATE306493T1 (de) 1997-04-30 1998-04-28 C22-stereospezifische herstellung von pregnan-16, 17-acetal derivaten
US09/067,711 US6169178B1 (en) 1997-04-30 1998-04-28 Process for the preparation of 16,17 acetals of pregnane derivatives with control of the epimeric distribution at the C-22 position
ES98107888T ES2251047T3 (es) 1997-04-30 1998-04-28 Procedimiento de preparacion estereoespecifica en la posicion c-22 de los 16,17 -acetales del pregnano.
EP98107888A EP0875516B1 (en) 1997-04-30 1998-04-28 Process for the preparation of 16,17 acetals of pregnane derivatives with control of the epimeric distribution at the C-22 position

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97MI001011A IT1291288B1 (it) 1997-04-30 1997-04-30 Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.

Publications (3)

Publication Number Publication Date
ITMI971011A0 true ITMI971011A0 (US06559137-20030506-C00166.png) 1997-04-30
ITMI971011A1 ITMI971011A1 (it) 1998-10-30
IT1291288B1 IT1291288B1 (it) 1999-01-07

Family

ID=11377043

Family Applications (1)

Application Number Title Priority Date Filing Date
IT97MI001011A IT1291288B1 (it) 1997-04-30 1997-04-30 Processo per la preparazione di 16,17 acetali di derivati pregnanici con controllo della distribuzione epimerica al c-22.

Country Status (6)

Country Link
US (1) US6169178B1 (US06559137-20030506-C00166.png)
EP (1) EP0875516B1 (US06559137-20030506-C00166.png)
AT (1) ATE306493T1 (US06559137-20030506-C00166.png)
DE (1) DE69831829D1 (US06559137-20030506-C00166.png)
ES (1) ES2251047T3 (US06559137-20030506-C00166.png)
IT (1) IT1291288B1 (US06559137-20030506-C00166.png)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1302657B1 (it) * 1998-10-13 2000-09-29 Farmabios Srl Processo stereoselettivo per la preparazione di budesonide nella formadi epimero 22-r.
CA2714653A1 (en) * 2008-03-13 2009-09-17 Farmabios S.P.A. Process for the preparation of pregnane derivatives
ITMI20080645A1 (it) 2008-04-11 2009-10-12 Ind Chimica Srl Procedimento per la preparazione di budesonide
LT2805720T (lt) 2008-05-28 2019-09-25 Reveragen Biopharma, Inc. Nehormoniniai steroidiniai nf-kb moduliatoriai, skirti ligoms gydyti
WO2011127048A2 (en) 2010-04-05 2011-10-13 Validus Biopharma NON-HORMONAL STEROID MODULATORS OF NF-ĸB FOR TREATMENT OF DISEASE
US10233210B2 (en) 2015-01-30 2019-03-19 Coral Drugs Pvt. Ltd. Process for preparation of glucocorticoid steroids
US10799514B2 (en) 2015-06-29 2020-10-13 Reveragen Biopharma, Inc. Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
WO2018033939A1 (en) * 2016-08-16 2018-02-22 Avik Pharmaceutical Limited Industrial ecological process of manufacturing of budesonide
CN108191938B (zh) * 2018-01-11 2019-07-05 湖南新合新生物医药有限公司 9,11烯烃甾族化合物的制备方法
US11382922B2 (en) 2019-03-07 2022-07-12 Reveragen Biopharma, Inc. Aqueous oral pharmaceutical suspension compositions

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998433A (en) 1960-07-22 1961-08-29 American Cyanamid Co 2alpha-halo-4, 9(11), 16-pregnatriene-3, 20-diones
US3047468A (en) 1961-06-06 1962-07-31 American Cyanamid Co Method of preparing delta1, 4-3-keto steroids of the pregnane series
US3549498A (en) * 1968-04-02 1970-12-22 Squibb & Sons Inc 11alpha-substituted steroids and process
SE378109B (US06559137-20030506-C00166.png) 1972-05-19 1975-08-18 Bofors Ab
SE378110B (US06559137-20030506-C00166.png) 1972-05-19 1975-08-18 Bofors Ab
NL7412537A (nl) * 1974-05-17 1975-11-19 Lark Spa Werkwijze voor het bereiden van 16.17-cyclische acetalen en ketalen van 9-(alpha)-halogeensteroiden.
DE3133631A1 (de) * 1981-08-21 1983-03-03 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue kortikoide ihre herstellung und verwendung
IT1196142B (it) * 1984-06-11 1988-11-10 Sicor Spa Procedimento per la preparazione di 16,17-acetali di derivati pregnanici e nuovi composti ottenuti
SE8604059D0 (sv) 1986-09-25 1986-09-25 Astra Pharma Prod A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
SE8903219D0 (sv) 1989-10-02 1989-10-02 Astra Ab Process for the manufacture of budesonide
PL164294B1 (pl) * 1990-12-20 1994-07-29 Inst Farmaceutyczny Sposób otrzymywania diastereoizomeru /22R/-16a , 17a-butylidenodioksy-11 ß 21-dihydroksy-1,4-pregnadien-3,20-dionu PL
SE9100341D0 (sv) * 1991-02-04 1991-02-04 Astra Ab Novel steroids
FR2675146A1 (fr) * 1991-04-10 1992-10-16 Roussel Uclaf Nouveaux derives sterouides de la pregna-1,4-diene-3,20-dione, leur preparation, leur application a la preparation de derives 16,17-methylene dioxy substitues et nouveaux intermediaires.

Also Published As

Publication number Publication date
ITMI971011A1 (it) 1998-10-30
ES2251047T3 (es) 2006-04-16
EP0875516A2 (en) 1998-11-04
DE69831829D1 (de) 2006-02-23
US6169178B1 (en) 2001-01-02
EP0875516A3 (en) 2000-04-12
EP0875516B1 (en) 2005-10-12
ATE306493T1 (de) 2005-10-15
IT1291288B1 (it) 1999-01-07

Similar Documents

Publication Publication Date Title
BE2018C032I2 (US06559137-20030506-C00166.png)
CH0944937H2 (US06559137-20030506-C00166.png)
ITMI971011A0 (US06559137-20030506-C00166.png)
IN189871B (US06559137-20030506-C00166.png)
ITMI971375A0 (US06559137-20030506-C00166.png)
ITMI971176A0 (US06559137-20030506-C00166.png)
BR9700653A (US06559137-20030506-C00166.png)
ITMI970392V0 (US06559137-20030506-C00166.png)
IN183712B (US06559137-20030506-C00166.png)
BR9701757A (US06559137-20030506-C00166.png)
CN3058531S (US06559137-20030506-C00166.png)
CN3053170S (US06559137-20030506-C00166.png)
CN3057976S (US06559137-20030506-C00166.png)
CN3059549S (US06559137-20030506-C00166.png)
CN3058025S (US06559137-20030506-C00166.png)
CN3057730S (US06559137-20030506-C00166.png)
CN3058057S (US06559137-20030506-C00166.png)
CN3054099S (US06559137-20030506-C00166.png)
CN3058088S (US06559137-20030506-C00166.png)
CN3058162S (US06559137-20030506-C00166.png)
CN3058320S (US06559137-20030506-C00166.png)
CN3058462S (US06559137-20030506-C00166.png)
CN3057614S (US06559137-20030506-C00166.png)
CN3058923S (US06559137-20030506-C00166.png)
CN3058533S (US06559137-20030506-C00166.png)

Legal Events

Date Code Title Description
0001 Granted